2,922
edits
Natural therapeutics: Difference between revisions
→Cancers and cannabis: + 'Integrating cannabis into clinical cancer care', a 2016 study published in the journal w:Current Oncology
(Pancreatic cancer and cannabis + 'GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine', a 2018 study published in Oncogene. Forbes.com news item on the study 'Study: CBD From Marijuana Plus Chemotherapy Tripled Cancer Survival Rates In Mice') |
(→Cancers and cannabis: + 'Integrating cannabis into clinical cancer care', a 2016 study published in the journal w:Current Oncology) |
||
| Line 430: | Line 430: | ||
* [https://www.theroc.us/researchlibrary/Cannabidiol%20as%20potential%20anticancer%20drug.pdf "Cannabidiol as potential anticancer drug",a 2017 paper published in the British Journal of Clinical Pharmacology] | * [https://www.theroc.us/researchlibrary/Cannabidiol%20as%20potential%20anticancer%20drug.pdf "Cannabidiol as potential anticancer drug",a 2017 paper published in the British Journal of Clinical Pharmacology] | ||
* [http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B0%5D=26983&path%5B1%5D=85698 'The heterogeneity and complexity of Cannabis extracts as antitumor agents'], a 2019 research paper published in [[w:Oncotarget]] | * [http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B0%5D=26983&path%5B1%5D=85698 'The heterogeneity and complexity of Cannabis extracts as antitumor agents'], a 2019 research paper published in [[w:Oncotarget]] | ||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/ 'Integrating cannabis into clinical cancer care'], a 2016 study published in the journal [[w:Current Oncology]] | |||
''' Ongoing and upcoming cannabis and cancer ''' | ''' Ongoing and upcoming cannabis and cancer ''' | ||